CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The combined use of scRNA-seq and network propagation highlights key features of pan-cancer Tumor-Infiltrating T cells.
The combined use of scRNA-seq and network propagation highlights key features of pan-cancer Tumor-Infiltrating T cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
提高药物的选择性和有效性是免疫肿瘤学未来治疗发展的关键问题。在此背景下,传统的大块转录组学在靶点发现的早期阶段存在局限性,因为所得基因表达水平代表的是多个细胞群体的平均测量值。相比之下,单细胞 RNA 测序可以深入探究独特细胞群体的转录组,有助于识别特定靶点。在这里,我们从单细胞 RNA-seq 泛癌 T 细胞图谱中生成了肿瘤浸润性调节性 T 细胞(TI-Tregs)和耗竭 T 细胞(Tex)基因特征。为了克服单细胞转录组学固有的噪声和稀疏性,我们随后使用 Patrimony 高通量计算平台,通过在蛋白质-蛋白质相互作用网络中进行扩散来传播这些基因特征。这种方法通过基于基因的生物学连通性重新评分来优化特征,不仅揭示了 TI-Treg 和 Tex 发育与功能的过程特征,还揭示了它们的免疫代谢特异性。
因此,单细胞转录组学与网络传播的结合使用可能代表一种创新且有效的方法,用于表征感兴趣的细胞群体,并最终推动免疫肿瘤学中新治疗策略的开发。
Improving the selectivity and effectiveness of drugs represents a crucial issue for future therapeutic developments in immuno-oncology. Traditional bulk transcriptomics faces limitations in this context for the early phase of target discovery as resulting gene expression levels represent the average measure from multiple cell populations. Alternatively, single cell RNA sequencing can dive into unique cell populations transcriptome, facilitating the identification of specific targets.
Here, we generated Tumor-Infiltrating regulatory T cells (TI-Tregs) and exhausted T cells (Tex) gene signatures from a single cell RNA-seq pan-cancer T cell atlas. To overcome noise and sparsity inherent to single cell transcriptomics, we then propagated the gene signatures by diffusion in a protein-protein interaction network using the Patrimony high-throughput computing platform.
This methodology enabled the refining of signatures by rescoring genes based on their biological connectivity and shed light not only on processes characteristics of TI-Treg and Tex development and functions but also on their immunometabolic specificities. The combined use of single cell transcriptomics and network propagation may thus represent an innovative and effective methodology for the characterization of cell populations of interest and eventually the development of new therapeutic strategies in immuno-oncology.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。